Category: Felzartamab
-
Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024
•
This section is Partnership content provided The content in this section is provided by GlobeNewswire for the purposes of press release distribution on behalf of its clients. Postmedia has not reviewed the content. by Globe Newswire Breadcrumb links Globe Newswire Article writer: Posted on October 26, 2024 • 6 minutes…
-
Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024
•
This section is Partnership content provided The content in this section is provided by GlobeNewswire for the purposes of press release distribution on behalf of its clients. Postmedia has not reviewed the content. by Globe Newswire Breadcrumb links Globe Newswire Article writer: Posted on October 26, 2024 • 6 minutes…